Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Thioctic Acid Amide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.87 |
| ▸ | TARDBP | Q13148 | 2/20 | 0.87 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | THRB | P10828 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | ACHE | P22303 | 1/20 | 0.66 |
| ▸ | APEX1 | P27695 | 1/20 | 0.66 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
| ▸ | BLM | P54132 | 1/20 | 0.66 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.66 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thioctic Acid Amide SCHEMBL50599 | 0.93 | KMT2A (1.00) | KMT2ATARDBPHSD17B10CYP2C9MEN1 | |
| Thioctic Acid Amide SCHEMBL13093778 | 0.93 | KMT2A (1.00) | KMT2ATARDBPHSD17B10CYP2C9MEN1 | |
| Thioctic Acid Amide SCHEMBL4380181 | 0.93 | KMT2A (1.00) | KMT2ATARDBPHSD17B10CYP2C9MEN1 | |
| Thioctic Acid Amide SCHEMBL41833 | 0.93 | KMT2A (1.00) | KMT2ATARDBPHSD17B10CYP2C9MEN1 | |
| SCHEMBL27494633 | 0.92 | KMT2A (0.96) | KMT2ATARDBPHSD17B10CYP2C9MEN1 | |
| Thioctic Acid Amide SCHEMBL28076123 | 0.92 | KMT2A (0.96) | KMT2ATARDBPHSD17B10CYP2C9MEN1 | |
| SCHEMBL29249630 | 0.92 | KMT2A (0.96) | KMT2ATARDBPHSD17B10CYP2C9MEN1 | |
| Thioctic Acid Amide SCHEMBL16653981 | 0.92 | KMT2A (0.96) | KMT2ATARDBPHSD17B10CYP2C9MEN1 | |
| SCHEMBL7841850 | 0.88 | KMT2A (0.89) | KMT2ATARDBPHSD17B10CYP2C9MEN1 | |
| Thioctic Acid Amide SCHEMBL1895286 | 0.87 | HSD17B10 (0.87) | KMT2ATARDBPHSD17B10CYP2C9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8742013-B2 | Synthesis of lipoamide-grafted high molecular compound and method therefor | Seoul National University of Technology Center for Industrial Collaboration (KR) | 2014-06-03 | — | — | US | disclosed |
| EP-2251359-A1 | Synthesis of Lipoamide-Grafted High Molecular Compound and Method Therefor | Seoul National University of Technology Center for Industry Collaboration (KR) | 2010-11-17 | — | — | EP | disclosed |
| US-20100272761-A1 | SYNTHESIS OF LIPOAMIDE-GRAFTED HIGH MOLECULAR COMPOUND AND METHOD THEREFOR | Seoul National University of Technology Center for Industrial Collaboration (KR) | 2010-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100272761-A1 | SYNTHESIS OF LIPOAMIDE-GRAFTED HIGH MOLECULAR COMPOUND AND METHOD THEREFOR | HDGF, HASPIN, LIPE | KMT2A 2886/4885TARDBP 3351/4885HSD17B10 1295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.